<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/98394315-AC6B-49E6-BFA9-244DD8616C93"><gtr:id>98394315-AC6B-49E6-BFA9-244DD8616C93</gtr:id><gtr:firstName>Dunecan</gtr:firstName><gtr:surname>Massey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800383"><gtr:id>992634D3-167F-44BE-B4FF-310955B5E2F9</gtr:id><gtr:title>Autophagy and Crohn's disease: translating genetics to function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800383</gtr:grantReference><gtr:abstractText>I aim to investigate the molecular biology of Crohn?s disease (CD), a chronic debilitating inflammatory bowel condition affecting 100 - 250 per 100,000 people in the UK. Although current understanding suggests that an abnormal response to bacteria living in the gut leads to Crohn?s inflammation, the mechanisms are not understood - yet understanding this mechanism might permit development of improved treatments or even preventative measures. Recent groundbreaking studies have highlighted two genes involved in autophagy as being significantly associated with CD risk. I will study one of these genes, ATG16L1. Autophagy is a cellular process that degrades unwanted large proteins and other cell structures, and is also implicated in clearance of invasive bacteria. We hypothesise that autophagy is abnormal in CD, leading to defective clearance of bowel pathogens and therefore inflammation. A series of experiments are proposed to test this hypothesis. Using established cell lines from animals and humans, and bowel samples from patients with CD, I will study the effects of the CD-associated variant in ATG16L1 on autophagy, characterize cellular components with which Atg16L1 protein interacts and investigate whether autophagy is generally abnormal in CD even without the currently identified genetic variants.</gtr:abstractText><gtr:technicalSummary>Within the last year genetic studies have identified robust association between a variant (T300A) in the autophagy gene ATG16L1, and susceptibility to Crohn?s disease (CD). Working in Professor Rubinsztein?s laboratory at the CIMR I aim to investigate the mechanism by which the disease-associated variant predisposes to CD, and whether autophagy is dysregulated in CD. The experiments proposed will address three key questions:
1. Does the ATG16L1 T300A variant affect mammalian autophagy?
2. Is autophagy generally perturbed in Crohn?s disease?
3. What proteins interact with Atg16?
Experiments in cell lines include: 
-SiRNA knock-down of native APG16 in mouse embryonic fibroblasts, replacement with wild-type/T300A variant ATG1L1, measurement of autophagy; 
-Comparison of autophagy in transformed human lymphoblastoid cells homozygous for ATG16L1 wild-type/T300A mutation 
-Identification of novel interactors for human Atg16 in epithelial and macrophage cell lines using immuno-affinity purification and mass spectroscopy
Other experiments: 
-Measurement of autophagy in normal/inflamed bowel biopsies from patients with CD/normal controls. 
-I will also localise and quantify ATG16L1 expression using immunohistochemistry and rt-PCR. 
This project offers training in advanced cell biology in an area of cutting-edge medical science within a world-class research institute, and will be the foundation of my career in academic gastroenterology.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>251458</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>11C52D85-8D6C-4E3A-9E2A-C0A36F296ED3</gtr:id><gtr:title>Genetics of inflammatory bowel disease: clues to pathogenesis.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>00DCD6E1F0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C129700-EECF-4C65-8543-EC3E1907D4B0</gtr:id><gtr:title>Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>LG6mfUpDruR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>718B6BEA-7F24-411B-872E-73734D990034</gtr:id><gtr:title>Mammalian macroautophagy at a glance.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>266511E4A9B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA7B4889-E085-4700-B464-448383FC0D94</gtr:id><gtr:title>Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d89b052dd4e2a10362d49aec3d8475f8"><gtr:id>d89b052dd4e2a10362d49aec3d8475f8</gtr:id><gtr:otherNames>Lewis GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>T43zrrr4hho</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C50D5195-8617-4E52-8445-A61906BA6026</gtr:id><gtr:title>Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>826E9B94E38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5CA1375-6E5F-4751-AC26-DEEAAF39ED0F</gtr:id><gtr:title>Use of sirolimus (rapamycin) to treat refractory Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41b039192d16b0458db0b78c7229c7a9"><gtr:id>41b039192d16b0458db0b78c7229c7a9</gtr:id><gtr:otherNames>Massey DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>27AA17EB0FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DB62F37-58BA-4E4F-8BA3-ECBAFC66F654</gtr:id><gtr:title>Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41b039192d16b0458db0b78c7229c7a9"><gtr:id>41b039192d16b0458db0b78c7229c7a9</gtr:id><gtr:otherNames>Massey DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>3EDEA00DC02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>486EB1E1-FA61-4DE9-B7AE-2477B2E0AD9A</gtr:id><gtr:title>Common pathways in Crohn's disease and other inflammatory diseases revealed by genomics.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52945e80a2a2ff4cb3b0621b78f2ce61"><gtr:id>52945e80a2a2ff4cb3b0621b78f2ce61</gtr:id><gtr:otherNames>Massey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>70C12D737FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1BF7DEC-6B67-4BC2-8897-852DE6478019</gtr:id><gtr:title>Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>E97C696ECAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC1050FF-6C47-478E-BD04-FD719C998C72</gtr:id><gtr:title>Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebba47d1d715333776167c284fd2b084"><gtr:id>ebba47d1d715333776167c284fd2b084</gtr:id><gtr:otherNames>Tremelling M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>B07020C8AA3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AFF8987-9AE5-4735-A821-B2A44BB4C0CA</gtr:id><gtr:title>Regulation of mammalian autophagy in physiology and pathophysiology.</gtr:title><gtr:parentPublicationTitle>Physiological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c684afaa55830b389d7cc1f42d26dc86"><gtr:id>c684afaa55830b389d7cc1f42d26dc86</gtr:id><gtr:otherNames>Ravikumar B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-9333</gtr:issn><gtr:outcomeId>Jk2V8GnWLut</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A1B80AE-E074-41CF-AB8B-E89151C0EC5B</gtr:id><gtr:title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d0d23737bcf164813e93f774577d3e"><gtr:id>43d0d23737bcf164813e93f774577d3e</gtr:id><gtr:otherNames>UK IBD Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>6DE64E32609</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800383</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>